Loading...
3 results
Search Results
Now showing 1 - 3 of 3
- Stalling the course of neurodegenerative diseases: could cyanobacteria constitute a new approach toward therapy?Publication . Ramos, Vitória; Reis, Mariana; Ferreira, Leonor; Silva, Ana Margarida; Ferraz, Ricardo; Vieira, Mónica; Vasconcelos, Vitor; Martins, RosárioNeurodegenerative diseases (NDs) are characterized by progressive and irreversible neuronal loss, accompanied by a range of pathological pathways, including aberrant protein aggregation, altered energy metabolism, excitotoxicity, inflammation, and oxidative stress. Some of the most common NDs include Alzheimer’s Disease (AD), Parkinson’s Disease (PD), Multiple Sclerosis (MS), Amyotrophic Lateral Sclerosis (ALS), and Huntington’s Disease (HD). There are currently no available cures; there are only therapeutic approaches that ameliorate the progression of symptoms, which makes the search for new drugs and therapeutic targets a constant battle. Cyanobacteria are ancient prokaryotic oxygenic phototrophs whose long evolutionary history has resulted in the production of a plethora of biomedically relevant compounds with anti-inflammatory, antioxidant, immunomodulatory, and neuroprotective properties, that can be valuable in this field. This review summarizes the major NDs and their pathophysiology, with a focus on the anti-neurodegenerative properties of cyanobacterial compounds and their main effects.
- Production and characterization of natural and synthetic compounds for treating hormone resistant tumorsPublication . Oliveira, Ana Isabel; Pinho, Cláudia; Vieira, Mónica; Ferraz, Ricardo; Cruz, Agostinho; Prudêncio, CristinaFrom previous and on-going studies, natural compounds/extracts isolated from Taraxacum hispanicum, Ionic Liquids (ILs) based on ampicillin and quinoxalines emerged as potential anticancer. Although described as potentially antitumor compounds, the mechanisms undergoing cytotoxicity remain unknown. Therefore, production of these kind of compounds were carry out in order to have a better understanding of their bioactivity.
- Bridging cyanobacteria to neurodegenerative diseases: a new potential source of bioactive compounds against Alzheimer’s diseasePublication . Castaneda, Andrea; Ferraz, Ricardo; Vieira, Mónica; Cardoso, Isabel; Vasconcelos, Vítor; Martins, RosárioNeurodegenerative diseases (NDs) represent a drawback in society given the ageing population. Dementias are the most prevalent NDs, with Alzheimer’s disease (AD) representing around 70% of all cases. The current pharmaceuticals for AD are symptomatic and with no effects on the progression of the disease. Thus, research on molecules with therapeutic relevance has become a major focus for the scientific community. Cyanobacteria are a group of photosynthetic prokaryotes rich in biomolecules with confirmed activity in pathologies such as cancer, and with feasible potential in NDs such as AD. In this review, we aimed to compile the research works focused in the anti-AD potential of cyanobacteria, namely regarding the inhibition of the enzyme β-secretase (BACE1) as a fundamental enzyme in the generation of β-amyloid (Aβ), the inhibition of the enzyme acetylcholinesterase (AChE) lead to an increase in the availability of the neurotransmitter acetylcholine in the synaptic cleft and the antioxidant and anti-inflammatory effects, as phenomena associated with neurodegeneration mechanisms.